Treatment of kidney cancer includes several options, depending on the extent of your cancer and your general health. The two main treatments for tumors that are confined to the kidney are tumor removal (nephrectomy) and tumor ablation.
Tumor removal (nephrectomy)
Surgical removal of the cancer traditionally was accomplished through a procedure called radical nephrectomy. It’s an open surgical procedure performed through an abdominal or flank incision during which the kidney, the fat surrounding the kidney, and the adrenal gland or lymph nodes are removed.
However, several less invasive procedures are available to patients, which offer faster recovery time, shorter hospital stays, and less scarring. UCSD specializes in these procedures, which include laparoscopic radical nephrectomy and partial nephectomy.
Read more about UCSD's surgical options for kidney cancer.
Tumor ablation
Tumor ablation, also known as targeted ablation or directed ablation, destroys the tumor without surgically removing it. By precisely targeting the tumor, cancerous tissue can be destroyed while limiting damage to normal tissue. Tumor ablation may also offer a better chance of preserving kidney function in situations when multiple tumors are present.
Ablation can be accomplished during open surgery, laparoscopy, or percutaneously (through the skin). Examples of tumor ablation techniques include:
- Cryotherapy: A cycle of freezing and thawing to destroy the tumor
- Radio frequency ablation: A special needle is inserted into the tumor and electrical impulses are used to heat and destroy the tumor
- High-intensity focused ultrasound: Sound waves are used to heat and destroy the tumor
- Laser coagulation: A targeted laser beam destroys the tumor
Since tumor ablation is less invasive than traditional surgery methods, it’s often used in patients with very small, localized tumors and in patients who aren't good candidates for surgery because of health issues or age.
Other treatment options
Embolization:: A procedure that blocks blood flow to the tumor. It’s used both to shrink the tumor by blocking its source of nutrients and to stop a tumor from bleeding. Embolization is performed by an interventional radiologist, who inserts a small tube (catheter) into an artery in the groin, and directs it to the renal artery that supplies blood to the kidney and the tumor. Special liquid agents or tiny solid particles are injected into the artery to block the flow of blood. This technique can relieve symptoms in patients with inoperable tumors. It can also be helpful in shrinking a large tumor before surgery.
Although not a standard treatment for kidney cancer, embolization can be useful in patients who can’t tolerate surgery or ablation. It can also be used as an adjunct treatment to prevent a large tumor from bleeding during surgery.
Biologic therapy (immunotherapy): This type of treatment is designed to boost the body's immune system to more effectively fight off or destroy cancer cells. Generally, the primary immunotherapy drugs used are cytokines, proteins which activate the immune system. These drugs include interleukin-2 and interferon-alpha.
New biologic therapies are highly effective oral medications, sorafinid and sunitinib, which are currently approved for the treatment of patients with advanced kidney cancer. These medications are also being tested at UCSD in the ASSURE clinical trial in the United States and Canada for adjuvant treatment of large or high grade tumors after surgery.